Vident Advisory’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$376K	Buy	+8,606	New	+$376K	﹤0.01%	1200
2025 Q1	–	Sell	-5,863	Closed	-$236K	–	1600
2024 Q4	$236K	Buy	+5,863	New	+$236K	﹤0.01%	1259